Latest News - IRIDEX

Tuesday, July 18, 2017 | Management/Leadership, IRIDEX

Iridex Announces Appointment Of Ann Rhoads To Its Board Of Directors

Iridex Corporation announced the appointment of Ann Rhoads to the company's board of directors, Audit Committee, and Compensation Committee, effective immediately. "We are delighted to add…

Read the full story

Tuesday, February 28, 2017 | Product Releases, IRIDEX

Iridex Launches G-Probe Illuminate at the Annual American Glaucoma Society Meeting

Iridex has announced the availability of the G-Probe Illuminate, a new, FDA-cleared probe offering combined transillumination and laser fiber for targeted transscleral cyclophotocoagulation (CPC). The…

Read the full story

Monday, September 19, 2016 | Miscellaneous, IRIDEX

Iridex Completes Training of its Technology on Orbis Flying Eye Hospital

Iridex has announced the completion of training on the IQ 532 Laser System and an 810 nm OcuLight SLx for the permanent staff of the Orbis Flying Eye Hospital. Both the Iridex 810nm OcuLight SLx and t…

Read the full story

Wednesday, September 07, 2016 | Medical Studies, IRIDEX

Iridex Announces Long-Term Glaucoma Efficacy Data for Patients Treated with MicroPulse P3 Probe Technology

Iridex announced that data on its MicroPulse P3 (MP3) device powered by the same proprietary MicroPulse laser technology in the Iridex Cyclo G6 glaucoma laser system show long-term benefits for patien…

Read the full story

Monday, May 23, 2016 | Miscellaneous, IRIDEX

Iridex Supports 'Eyes of Africa' Program

Iridex Corp. has announced the donation of an 810 nm OcuLight SLx to the Eyes of Africa Project in Malawi. The Iridex 810nm OcuLight SLx is a multifunctional laser that can be used to perform retinal …

Read the full story

Tuesday, May 10, 2016 | Clinical Trials, IRIDEX

Iridex Announces Cyclo G6 with MicroPulse P3 Clinical Data Presented at ARVO and ASCRS

Iridex announced that data on its MicroPulse P3 device powered by the Cyclo G6 Glaucoma Laser System was presented at both the Association for Research in Vision and Ophthalmology (ARVO) 2016 annual m…

Read the full story

Tuesday, February 16, 2016 | CE Mark Approval, IRIDEX

Iridex Receives CE Mark for Cyclo G6 Laser System for the Treatment of Multiple Stages of Glaucoma

Iridex announced it has received CE Mark to commercialize across Europe the Cyclo G6, its first laser system designed solely for use in treating glaucoma and its symptoms. The Cyclo G6 laser system is…

Read the full story

Wednesday, September 09, 2015 | Product Releases, IRIDEX

Iridex Adds Tonometer to its Glaucoma Therapy Offerings

Iridex announced that it has added a tonometer to its suite of commercial products for the global glaucoma market. The new device comes to Iridex through a distribution agreement with Icare Finland, a…

Read the full story

Thursday, April 16, 2015 | Glaucoma, Product Releases, IRIDEX

Iridex Total Glaucoma Solution Campaign for US Market to Debut at ASCRS

Iridex announced the debut of its Total Glaucoma Solution, a commercial offering for the United States market focused on the company's growing portfolio of glaucoma products. The recent introducti…

Read the full story

Monday, March 30, 2015 | Glaucoma, Product Releases, IRIDEX

Iridex Granted US Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries

Iridex Corp. announced that the United States Patent and Trademark Office granted the company a patent for a new proprietary disposable device intended to replace certain suturing techniques in eye su…

Read the full story

Wednesday, March 18, 2015 | Glaucoma, IRIDEX

Iridex Announces First Commercial Sales of New Cyclo G6 Glaucoma Laser Systems

Iridex Corporation announced the first commercial sales of its new Cyclo G6 laser system, designed to treat patients diagnosed with a range of glaucoma disease states. The Cyclo G6 system includes a g…

Read the full story

Monday, February 23, 2015 | Product Releases, IRIDEX

Iridex To Debut Cyclo G6 Glaucoma Laser Platform and Present New Clinical Data at the American Glaucoma Society's Annual Meeting

Iridex announced that it will debut the Cyclo G6, the company’s first laser platform dedicated to the treatment of glaucoma, at this year’s annual congress of the American Glaucoma Society…

Read the full story

Monday, February 02, 2015 | FDA Approval/Clearance, Glaucoma, IRIDEX

Iridex Receives FDA Clearance for Cyclo G6 Laser System for the Treatment of Multiple Stages of Glaucoma

Iridex was granted 510(k) clearance for the Cyclo G6 Laser System, its first laser system designed solely for use in treating glaucoma and its symptoms, according to a company news release. The C…

Read the full story

Tuesday, December 02, 2014 | IRIDEX

Iridex Secures Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions

Iridex announced that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced o…

Read the full story

Thursday, October 16, 2014 | Product Releases, IRIDEX

Iridex Expands Retinal Portfolio

Iridex announced that it will introduce its new family of patented Adjustable & Intuitive Extended Reach (A&I XR) laser probes at the annual meeting of the American Academy of Ophthalmology to…

Read the full story